Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21911655 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Conditions: Amnestic Mild Cognitive Impairment;   Alzheimer's Disease
Interventions: Drug: Insulin (Humulin® R U-100);   Drug: Placebo
2 Completed SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Interventions: Drug: Regular Insulin;   Drug: Placebo

Indicates status has not been verified in more than two years